By www.marketscagr.com
Global Immuno-oncology Drugs Market Insights And Forecast To 2028 Story
125
$ 4900
Immuno-oncology Drugs Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Amgen, Inc AstraZeneca, Plc Bristol-Myers Squibb Celgene Corporation Eli Lilly and Company Merck & Co. Hoffmann-La Roche AG Johnson & Johnson Novartis International AG AbbVie, Inc. Pfizer Inc. Sanofi S.A. EMD Serono, Inc. Gilead Sciences Inc. Prometheus Therapeutics & Diagnostics Aduro BioTech Galena Biopharma Bavarian Nordic Celldex Therapeutics ImmunoCellular Therapeutics Incyte Dendreon Corporation Agilent Technologies Inc. Agenus Inc. Enzo Biochem, Inc. Lonza Group Bio-Rad Laboratories, Inc. Avantor, Inc. Spring Bank Pharmaceuticals, Inc. Ferring Pharmaceuticals